Manufacturer - BR PHARM Co., Ltd.

A Korean brand operating with highly developed technology in the field of regenerative medicine to provide comfort based on knowledge, science and the introduction of innovative technologies using PDRN.

BR PHARM has patented the technology for producing the cell cycle activator PDRN for the production of products in the field of regenerative and raw materials medicine (PDRN) and has a BGMP (Bulk Good Manufacture Practice) certificate issued by the Ministry of Food and Drug Safety. Moreover, BR PHARM cooperates with government institutions in the consumption and supply of safe PDRN medical raw material.

It bases its activities on three areas:

Pharmaceuticals – conducts extensive research and focuses on the development of drugs, such as PDRN-based drugs and aseptic injections.

Medical devices – development of joint syringes from PDRN and PN components, skin regeneration therapeutics, HA filters and lipolysis products.

Cosmeceuticals – supplies cosmeceuticals to approximately 3,500 hospitals and clinics in Korea based on 10 years of experience in the cosmetics industry.

The company's vision is to create its products based on knowledge transferred through communication, sensitivity and experience